Long-Term Safety and Efficacy of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma in the Era of Quadruplets
Michail Iskas(G. Papanikolaou General Hospital), Ioanna Sakellari(G. Papanikolaou General Hospital), Christos Demosthenous(G. Papanikolaou General Hospital), Eleni Gavriilaki(Aristotle University of Thessaloniki), Panagiotis Kalmoukos, Μαρία Παπαθανασίου(Goethe University Frankfurt), Marianna Masmanidou(G. Papanikolaou General Hospital), Ioannis Batsis(G. Papanikolaou General Hospital), Chrysavgi Lalayanni(G. Papanikolaou General Hospital), Panagiotis Dolgyras(G. Papanikolaou General Hospital), Anna Vardi(G. Papanikolaou General Hospital), Damianos Sotiropoulos(G. Papanikolaou General Hospital), Chrysanthi Vadikoliou(G. Papanikolaou General Hospital), Giorgos Karavalakis(G. Papanikolaou General Hospital), Zoi Bousiou(G. Papanikolaou General Hospital), Vasiliki Douka(G. Papanikolaou General Hospital), Nikolaos Spyridis(G. Papanikolaou General Hospital)
Cited by 0
Related Papers
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
|Leukemia|2021|94
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL
|Blood|2013|93
Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks
|Journal of Cellular and Molecular Medicine|2022|90
Genetic justification of severe COVID-19 using a rigorous algorithm
|Clinical Immunology|2021|63
Beta-thalassemia: renal complications and mechanisms: a narrative review
|Hematology|2019|62